OVCA2 and plasma cell myeloma: Also, in contrast with del17p being a marker of poor prognosis, our analysis of the FIMM dataset suggested that high expression of OVCA2 is associated with poor prognosis in multiple myeloma, despite low expression of OVCA2 being associated with del17p.